| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.44 | 0.06 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |